All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 6, 2022
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

In the clinic for June 27, 2022

June 27, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akston, Biolexis, Calithera, GSK, Intellia, Regeneron, Sanofi.
Read More

Sanofi-GSK’s beta-antigen COVID-19 vaccine posts strong numbers against omicron

June 24, 2022
By Lee Landenberger
No Comments
Sanofi SA and GSK plc said new phase III data show their adjuvanted bivalent D614 and beta (B.1.351) COVID-19 vaccine candidate responded well against omicron despite it being designed to fight the original SARS-CoV-2 virus and the beta variant.
Read More

Regulatory actions for June 24, 2022

June 24, 2022
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Alterity, Amryt, Astrazeneca, Biontech, CNS, Fusion, Menarini, Merck & Co., Novartis, Novavax, Radius, Realta, Rockwell, Valneva.
Read More
Coin inserted into Australian map

Pfizer revises Resapp offer on heels of failed data confirmation study

June 23, 2022
By Tamra Sami
No Comments
Pfizer Australia Holdings Pty Ltd. has revised its offer to acquire digital health company Resapp Health Ltd. after results from an independent data confirmation study of its COVID-19 algorithm failed to meet Pfizer’s required sensitivity and specificity results.
Read More
Wensheng Wei, founder, Therorna
Newco news

Chinese biotech Therorna completes $42M series A to develop circRNA COVID-19 vaccines

June 23, 2022
By Tamra Sami
No Comments
Chinese biotech company Therorna Inc. completed a $42 million series A round to develop its circular RNA (circRNA) vaccines and therapies.
Read More

Against the tide, Australia allows advertising COVID-19 antiviral drugs

June 23, 2022
By Tamra Sami
No Comments
In a rare move, Australia’s Therapeutic Goods Administration is allowing two prescription-only COVID-19 treatments to be advertised to the public.
Read More

Regulatory actions for June 23, 2022

June 23, 2022
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 3Spine.
Read More

Other news to note for June 23, 2022

June 23, 2022
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antisense, Apellis, Assembly, Athenex, Aura, Aveo, Chimerix, Cingulate, Coya, Cullinan Oncology, Evaxion, F-star, Immunicum, Innovation, Medc, Mendus, Medicinova, Mindset, Novartis, Pliant, Q32, Radius, Rubius, Sino, Taiho.
Read More

In the clinic for June 23, 2022

June 23, 2022
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aligos, Alpha Cognition, Athira, Biomea, Bridgebio, Cymabay, Galderma, Innocare, Intrommune, Moderna, Mycovia, Rakuten, Recce, Regenerx, SK, Vaccitech, Vistagen, Zucara, Zynerba.
Read More
Pharmaceutical manufacturing

Moderna invests in UK manufacturing and research, answering call to prep for fast response to future ‘Disease X’

June 22, 2022
By Richard Staines
No Comments
While the biopharma industry was widely praised for its fast response to the COVID-19 pandemic, moves are afoot to ensure that the world is better prepared in case another pandemic hits. Moderna Inc. was one of the companies that blazed a trail in the early stages of the pandemic with its revolutionary mRNA vaccine. Now the firm is investing in manufacturing and R&D in the U.K. to make good on a pledge to respond to the next global disease threat within 100 days of its detection.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 455 456 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2022.
  • Novavax-COVID-19-vaccine-vial

    Novavax vaccine shows its chops

    BioWorld
    Given that Novavax Inc.’s COVID-19 vaccine will be a latecomer to the U.S. scene if it gets FDA authorization, it’s been cast in a supporting role to the lead...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for July 6.
  • Blood sample, DNA

    Biomarin outlines pricing strategy for costly hemophilia A gene therapy after backing from European regulators

    BioWorld
    The first gene therapy to treat severe hemophilia A was among the drugs recommended for European approval by regulators from the EMA’s CHMP at its monthly...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing